Miguel A. Materin, MD

Assistant Professor of Ophthalmology & Visual Science
Director of Ocular Oncology

Email	miguel.materin@yale.edu
Phone	(203) 785-2020 (800) 395-7949 (Toll-free, Nationwide)
Fax	(203) 785-5909
Office Address	Department of Ophthalmology & Visual Science 40 Temple Street, Third Floor New Haven, CT 06510
Mailing Address	Department of Ophthalmology & Visual Science Yale University School of Medicine P.O. Box 208061 New Haven, CT 06520-8061

Professional Statement

Dr. Materin joined the Yale University School of Medicine on January 1, 2009 as Assistant Professor of Ophthalmology and Director of Ocular Oncology. His clinical practice involves diagnosis and treatment of patients with ocular tumors, including benign and malignant tumors of the eye. He has special interests in ocular melanoma, retinoblastoma, choroidal hemangiomas, retinal hemangiomas, metastases, astrocytic tumors and tumors related to other conditions or syndromes, like von Hippel Lindau disease among others.

Dr. Materin is an internationally recognized ocular oncologist, serving as a member of the International Advisory Board (Ocular Oncology) for the Canadian Journal of Ophthalmology, as well as journal reviewer for the British Journal of Ophthalmology and Retina, the Journal of Retina and Vitreous Diseases. He has published extensively in the peer-reviewed literature, including journals and book chapters. He has served as a visiting professor in US, Canada, Israel, Spain, Puerto Rico, Argentina, and gave lectures worldwide.

Dr. Materin has received the Achievement Award from the American Academy of Ophthalmology and he is a Member of Merit of Clinica Barraquer (Barcelona, Spain). He has served as Director of Diagnostic Studies at the Ocular Oncology Service at Wills Eye Hospital for 7 years. He is an active member of the International Society of Ocular Oncology, American Academy of Ophthalmology, Pan American Association of Ophthalmology and Argentine Society of Ophthalmology.

Clinical Interests

Early detection and treatment of ocular tumors; improving survival in patients with eye cancers; systemic cancers and ocular complications

Research Interests

Role of cytogenetics in ocular oncology for diagnosis and prognosis; improving diagnostic and treatment methods for eye tumors

Education & Training

Medical	University of Buenos Aires, Argentina
Residency	Santa Lucia Hospital, Buenos Aires, Argentina
Fellowship	Wills Eye Hospital, Thomas Jefferson University (Ocular Oncology)

Additional Information and Links

• Podcast
  • A Focus on Ocular Oncology
    Dr. Materin is interviewed for Yale Cancer Center Answers , a weekly radio show focused on cancer screening, detection, treatment, and prevention to provide the latest information to listeners in Connecticut.
• Videos
• Chromosomal tumor analysis for uveal melanoma
  Dr. Miguel A. Materin discusses chromosomal analysis within a tumor, the most important guide to clinical survival.
• A Focus on Ocular Oncology (Podcast)
  Dr. Miguel A. Materin is interviewed for Yale Cancer Center Answers , a weekly radio show focused on cancer screening, detection, treatment, and prevention to provide the latest information to listeners in Connecticut.
• Eye Tumors
  Dr. Miguel A. Materin discusses eye tumors ranging from benign to malignant ophthalmic cancers.
• Metastatic Eye Disease
  Dr. Miguel A. Materin discusses metastatic eye cancer that can be caused by any cancer, but most commonly carcinomas.
• Retinoblastoma
  Dr. Miguel A. Materin discusses retinoblastoma and the importance of germline vs somatic mutations in predicting prognosis.
• Retinoblastoma treatment options
  Dr. Miguel A. Materin discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).
• Uveal Melanoma
  Dr. Miguel A. Materin describes uveal melanoma, a rare cancer but the most common cause of intraocular cancer in adults.
• Ocular Oncology at the Yale Eye Center
• Download CV